Novel Airlift Single-use Bioreactor System for 1-100 Litre Pluripotent Stem Cell Production

Cellexus是由Gavin Hands、Yann Lecouturier和Brian Wales创立的。Cellexus正在开发一种新型的气升式一次性生物反应器(SUB)，专门用于1-100升规模的干细胞生产。它预计将产生2600万GB的项目后5年收入。该系统将有可能对再生医学、药物筛选过程、生物医学研究和其他商业和科学项目产生积极影响(Rodrigues等人，2011年)。

Cellexus was founded by Gavin Hands, Yann Lecouturier and Brian Wales. Cellexus is developing a novel airlift single-use bioreactor (SUB) dedicated to stem-cell production at a scale of 1--100 litres. It is expected to generate a year-5 post-project revenue of £26M. This system would have the potential to positively impact regenerative medicine, drug screen processes, biomedical research and other commercial and scientific projects (Rodrigues et al., 2011).